HDAC9 and cancer: These data have led to clinical studies using HDAC inhibitors in combination with current DNA damaging agents, such as topoisomerase inhibitors, DNA synthesis inhibitors, DNA intercalators and agents that covalently modify DNA, as treatment of several types of cancer [34]; [35].